Oversight and Investigations

Chairman:  Tim Murphy (PA-18)
Jurisdiction: 
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.

Members

Republicans

Chairman: Tim Murphy (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Steve Scalise (LA)
Gregg Harper (MS)
Pete Olson (TX)
Cory Gardner (CO)
Morgan Griffith (VA)
Bill Johnson (OH)
Billy Long (MO)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Diana DeGette (CO)
Bruce Braley (IA)
Ben Ray Lujan (NM)
Jan Schakowsky (IL)
G.K. Butterfield (NC)
Kathy Castor (FL)
Peter Welch (VT)
Paul Tonko (NY)
John Yarmuth (KY)
Gene Green (TX)
John D. Dingell (MI) (non-voting)
Henry A. Waxman (CA)

September 30, 2013 | Blog Post

The Obama administration’s signature health law is scheduled to officially launch tomorrow, but it appears the delays and missed deadlines that have plagued implementation will continue.

>>
September 30, 2013 | Press Release

WASHINGTON, DC – Energy and Commerce Committee leaders last week followed up on a previous committee staff request for briefings on the administration’s efforts and coordination regarding the use of cost estimates for the social cost of carbon (SCC) from agencies participating in an “Interagency Working Group on the Social Cost of Carbon.” According to the Environmental Protect

>>
September 28, 2013 | Press Release

WASHINGTON, DC – The House of Representatives today passed H.R. 3204, the Drug Quality and Security Act, by a voice vote.

>>
September 28, 2013 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) today kicked off debate on the bipartisan H.R. 3204, the Drug Quality and Security Act.

>>
September 27, 2013 | Fact Sheet

The Drug Quality and Security Act would address two important issues affecting the quality and security of America’s drug supply. First, the bill would protect traditional pharmacies and clarify laws related to human drug compounding in response to the nationwide meningitis outbreak – one of the largest public health crises in recent memory.

>>
September 27, 2013 | Press Release

“This compromise legislation addresses the issues that led to the NECC tragedy, protects the physician-patient-pharmacist relationship, maintains critical patient access to compounded medications, and strengthens the pharmaceutical supply chain.” - NCPA

>>

Pages